MediGene AG
FRA:MDG1 ISIN:DE000A161NA3
MediGene AG is a publicly listed (Frankfurt: MDG, Prime Standard, TecDAX) biotechnology company located in Martinsried/Munich, Germany, with subsidiaries in Oxford, UK and San Diego, USA. MediGene is the first German biotech company to have drugs on the market, which are being distributed by partner companies and has several drug candidates in clinical development, two of which provide significant sales potential. In addition, the company has numerous projects in research and pre-clinical development and possesses innovative platform technologies. MediGene focuses on the research and development of novel drugs for the treatment of cancer and autoimmune diseases
Sprache wählen
News
MediGene AG (FRA:MDG)(Prime Standard, TecDAX) announced today that Dr. Peter Heinrich, Chief Executive Officer, has resigned from his position as member of the Executive Board with immediate effect. The Supervisory Board has accepted the resignation with great regret.
###
12,839 COMPANY PROFILE VIEWS
- Diese Seite wurde besucht: (letzten 7 Tagen: 5) (letzten 30 Tagen: 21) (seit Veröffentlichung: 4385)
